Well I don't think they'll be loading up exactly. Did you buy shares in Gillette after you bought one of their razors? Those guys bought a "machine", a piece of equipment, not a stake in Arrayit (and a very low profit machine at that). Now, with that equipment they have the same "machine" that Arrayit has and can do the same type of work. In fact, they might be using their machine to develop a better test for Ovarian Cancer. What people don't seem to understand is that everything Arrayit sells, except for the allergy test, is a sale to one of their competitors. Yep, every company that buys an Arrayit Microarray "whatever" is out there trying to eat Arrayit's lunch and Arrayit is there to help them. That's why I don't do cartwheels everytime Mark hypes one of his sales to a "leading edge" this or a "top" that. He's just telling us that the competition is moving on ahead of us and with our help. Where are our own researchers and what are they researching? What new discoveries are about to unfold down at Arrayit headquarters? Do we even have a research team? Someone should ask those questions of Mark.
Market Data 
Markets 
